1

From reading about clinical studies on various chronic diseases, I get a sense that increasing lifespan is rarely the primary objective of these studies, and instead they focus on surrogate markers, like blood pressure or blood sugar. Is it generally important for a drug to have a reduced mortality compared to placebo for it to be approved by FDA, etc?

0

Your Answer

By clicking “Post Your Answer”, you agree to our terms of service, privacy policy and cookie policy

Browse other questions tagged or ask your own question.